DrugPatentWatch Database Preview
Ozanimod hydrochloride - Generic Drug Details
What are the generic drug sources for ozanimod hydrochloride and what is the scope of freedom to operate?
Ozanimod hydrochloride
is the generic ingredient in one branded drug marketed by Celgene Intl and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Ozanimod hydrochloride has one hundred and forty-two patent family members in thirty countries.
One supplier is listed for this compound.
Summary for ozanimod hydrochloride
| International Patents: | 142 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 19 |
| What excipients (inactive ingredients) are in ozanimod hydrochloride? | ozanimod hydrochloride excipients list |
| DailyMed Link: | ozanimod hydrochloride at DailyMed |
Recent Clinical Trials for ozanimod hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bristol-Myers Squibb | Phase 1 |
| François Lellouche | Phase 2 |
| Bristol-Myers Squibb | Phase 2 |
US Patents and Regulatory Information for ozanimod hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-001 | Mar 25, 2020 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-003 | Mar 25, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-002 | Mar 25, 2020 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-003 | Mar 25, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Celgene Intl | ZEPOSIA | ozanimod hydrochloride | CAPSULE;ORAL | 209899-002 | Mar 25, 2020 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ozanimod hydrochloride
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2913326 | ⤷ Try it Free |
| Eurasian Patent Organization | 201690391 | ⤷ Try it Free |
| New Zealand | 589617 | ⤷ Try it Free |
| Denmark | 2498610 | ⤷ Try it Free |
| Norway | 2498610 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ozanimod hydrochloride
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2291080 | 122020000055 | Germany | ⤷ Try it Free | PRODUCT NAME: OZANIMOD ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE OZANIMODHYDROCHLORID; REGISTRATION NO/DATE: EU/1/20/1442 20200520 |
| 2498610 | 2020C/544 | Belgium | ⤷ Try it Free | PRODUCT NAME: OZANIMOD OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, EN PARTICULIER LE CHLORHYDRATE D'OZANIMOD; AUTHORISATION NUMBER AND DATE: EU/1/20/1442 20200525 |
| 2291080 | C02291080/01 | Switzerland | ⤷ Try it Free | PRODUCT NAME: OZANIMOD; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67046 11.08.2020 |
| 2291080 | 40/2020 | Austria | ⤷ Try it Free | PRODUCT NAME: OZANIMOD ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE OZANIMODHYDROCHLORID; REGISTRATION NO/DATE: EU/1/20/1442 (MITTEILUNG) 20200525 |
| 2498610 | 301076 | Netherlands | ⤷ Try it Free | PRODUCT NAME: OZANIMOD OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER OZANIMODHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/20/1442 20200525 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
